Advertisement Pharmaceutical Business review - Page 269 of 5272 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
May 7, 2026

Halozyme and Oruka sign agreement for Hypercon technology

Halozyme Hypercon has signed an exclusive global collaboration and licence agreement with Oruka Therapeutics for the development of ORKA-001 using Hypercon Technology.

Continue
The Hypercon technology makes drug administration patient-friendly. Credit: Premreuthai / Shutterstock.com.
May 6, 2026

Citius raises $36.5m for Lymphir commercialisation

Proceeds will fund Lymphir’s commercialisation, market access, medical affairs, and manufacturing. Credit: Gorodenkoff / Shutterstock.com.
May 5, 2026

Lannett, Lanexa Biologics and Sunshine Lake secure FDA approval for Langlara

The FDA decision followed studies showing Langlara matched Lantus in pharmacokinetics, efficacy, safety, and immunogenicity for diabetes. Credit: Lannett Company / Business Wire.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. MSD concludes Terns acquisition to expand CML pipeline
  2. Latus Bio secures $97m in funding to boost gene therapy access
  3. Arrowhead’s Redemplo secures Australian TGA approval for FCS therapy
  4. Novo Nordisk to launch Ozempic for type 2 diabetes in US
  5. Axsome receives FDA approval for Auvelity to treat Alzheimer’s agitation

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography